Rigenerand’s founder, Massimo Dominici MD, has been listed once again by The Medicine Maker, leading international magazine for pharmaceutical development, as one of the 60 best leaders and opinion makers in the industry. Prof. Massimo Dominici is the only Italian of the 20 honored in the category Advanced Medicine this year (which includes therapies based on cells, also genetically modified ones). For Prof. Dominici this is an affirmation as he had been already listed in 2019.

The Medicine Maker is a leading international magazine for cell and gene therapy that creates an annual list of the world’s 60 best leaders and opinion makers whose work has contributed to a significant progress in the biopharmaceutical industry and therefore in medicine.

“I am honored by this recognition – commented Prof. Massimo Dominici – that celebrates the work accomplished by me and my coworkers in the Laboratories for Cell Therapy Research of the University Hospital Modena and the company Rigenerand. Our goal is to transfer years of research on cells to various branches of medicine and surgery, also thanks to a wide range of international collaborations. Our vocation is to serve as platform for the development of cell therapies by ourselves and as CDMO for all of those who believe in cells as medicinal products.”

The Power List of The Medicine Maker is created by a group of experts who analyze the work done in the industry, the visibility and the number of citations of the scientific pubblications of those authors. This year’s categories were Small Molecules, Advanced Medicine and Biopharmaceuticals, with 20 leaders for each category.

https://themedicinemaker.com/power-list/2020